Thomas Jefferson University

Eugene Storozynsky

TitleFaculty Physician
InstitutionThomas Jefferson University
DepartmentCardiology - Thomas Jefferson University
Address925 Chestnut Street
Philadelphia PA 19107
Phone215-955-5050
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Rahimov D, Yan VZ, Ahmad D, Nasher N, Tatum R, Im M, Storozynsky E, Rame JE, Rajagopal K, Entwistle JW, Massey HT, Tchantchaleishvili V. Characteristics and outcomes of cardiac amyloid disease after heart transplantation: A systematic review and meta-analysis. Transplant Rev (Orlando). 2025 04; 39(2):100908. PMID: 39981794.
      Citations:    
    2. Gamero MT, Patel A, Storozynsky E. The Good (Tumor Killing) and the Bad (Cardiovascular Complications) of Immunologic Checkpoint Inhibitors. Curr Cardiol Rep. 2024 12; 26(12):1487-1498. PMID: 39441327.
      Citations:    
    3. Choi W, Jia Y, Kwak J, Werner-Wasik M, Dicker AP, Simone NL, Storozynsky E, Jain V, Vinogradskiy Y. Novel Functional Radiomics for Prediction of Cardiac Positron Emission Tomography Avidity in Lung Cancer Radiotherapy. JCO Clin Cancer Inform. 2024 03; 8:e2300241. PMID: 38452302.
      Citations:    
    4. Gomaa S, Kelly WK, Mitchell E, Storozynsky E, Zeigler-Johnson C, Juon HS, Wen KY. Racial disparities in new-onset diabetes mellitus in prostate cancer patients on androgen deprivation therapy: a retrospective analysis of TriNetX data. World J Urol. 2023 Sep; 41(9):2351-2357. PMID: 37555986.
      Citations:    
    5. Mitchell J, Storozynsky E, Lopez AM. The Nuance of Studying and Prescribing Supplements. J Am Coll Cardiol. 2023 05 02; 81(17):e149. PMID: 37100494.
      Citations:    
    6. Fradin J, Kim FJ, Lu-Yao GL, Storozynsky E, Kelly WK. Review of Cardiovascular Risk of Androgen Deprivation Therapy and the Influence of Race in Men with Prostate Cancer. Cancers (Basel). 2023 Apr 15; 15(8). PMID: 37190244.
      Citations:    
    7. Sherazi S, Schleede S, McNitt S, Casulo C, Moore JE, Storozynsky E, Patel A, Vidula N, Aktas MK, Zent CS, Goldenberg I. Arrhythmogenic Cardiotoxicity Associated With Contemporary Treatments of Lymphoproliferative Disorders. J Am Heart Assoc. 2023 03 21; 12(6):e025786. PMID: 36892046.
      Citations:    
    8. Irabor OC, Nelson N, Shah Y, Niazi MK, Poiset S, Storozynsky E, Singla DK, Hooper DC, Lu B. Overcoming the cardiac toxicities of cancer therapy immune checkpoint inhibitors. Front Oncol. 2022; 12:940127. PMID: 36185227.
      Citations:    
    9. Attin M, Reifenstein K, Mehta S, Arcoleo K, Lin CD, Storozynsky E. Reported Signs, Symptoms, and Diagnostic Tests Before Cardiotoxicity Among Women With Breast Cancer: A Pilot Study. J Cardiovasc Nurs. 2022 Mar-Apr 01; 37(2):104-111. PMID: 34369915.
      Citations:    
    10. Ayers BC, Wood K, McNitt S, Goldenberg I, Chen L, Alexis J, Vidula H, Thomas S, Storozynsky E, Barrus B, Prasad S, Gosev I. Association of previous cardiac surgery with outcomes in left ventricular assist device patients. Interact Cardiovasc Thorac Surg. 2020 07 01; 31(1):1-8. PMID: 32248242.
      Citations:    
    11. Lee EC, McNitt S, Martens J, Bruckel JT, Chen L, Alexis JD, Storozynsky E, Thomas S, Gosev I, Barrus B, Goldenberg I, Vidula H. Long-term milrinone therapy as a bridge to heart transplantation: Safety, efficacy, and predictors of failure. Int J Cardiol. 2020 08 15; 313:83-88. PMID: 32320777.
      Citations:    
    12. Ayers B, Sagebin F, Wood K, Barrus B, Thomas S, Storozynsky E, Chen L, Bernstein W, Lebow B, Prasad S, Gosev I. Complete Sternal-Sparing Approach Improves Outcomes for Left Ventricular Assist Device Implantation in Patients With History of Prior Sternotomy. Innovations (Phila). 2020 Jan/Feb; 15(1):51-56. PMID: 31903870.
      Citations:    
    13. Sagebin FM, Ayers BC, Wood K, Barrus B, Chen L, Alexis J, Vidula H, Thomas S, Storozynsky E, Prasad S, Gosev I. Extracorporeal life support to ventricular assist device: potential benefits of sternal-sparing approach. J Thorac Dis. 2019 Nov; 11(11):4790-4797. PMID: 31903269.
      Citations:    
    14. Schaffer K, Panneerselvam N, Loh KP, Herrmann R, Kleckner IR, Dunne RF, Lin PJ, Heckler CE, Gerbino N, Bruckner LB, Storozynsky E, Ky B, Baran A, Mohile SG, Mustian KM, Fung C. Systematic Review of Randomized Controlled Trials of Exercise Interventions Using Digital Activity Trackers in Patients With Cancer. J Natl Compr Canc Netw. 2019 01; 17(1):57-63. PMID: 30659130.
      Citations:    
    15. Barsheshet A, Kutyifa V, Vamvouris T, Moss AJ, Biton Y, Chen L, Storozynsky E, Wan C, Szymkiewicz SJ, Goldenberg I. Study of the wearable cardioverter defibrillator in advanced heart-failure patients (SWIFT). J Cardiovasc Electrophysiol. 2017 Jul; 28(7):778-784. PMID: 28429542.
      Citations:    
    16. Sherazi S, Kutyifa V, McNitt S, Papernov A, Hallinan W, Chen L, Storozynsky E, Johnson BA, Strawderman RL, Massey HT, Zareba W, Alexis JD. Effect of Gender on the Risk of Neurologic Events and Subsequent Outcomes in Patients With Left Ventricular Assist Devices. Am J Cardiol. 2017 Jan 15; 119(2):297-301. PMID: 27839770.
      Citations:    
    17. Russell RR, Alexander J, Jain D, Poornima IG, Srivastava AV, Storozynsky E, Schwartz RG. The role and clinical effectiveness of multimodality imaging in the management of cardiac complications of cancer and cancer therapy. J Nucl Cardiol. 2016 08; 23(4):856-84. PMID: 27251147.
      Citations:    
    18. Storozynsky E. Multimodality assessment and treatment of chemotherapy-induced cardiotoxicity. Future Cardiol. 2015 Jul; 11(4):421-4. PMID: 26238563.
      Citations:    
    19. Schwartz RG, Jain D, Storozynsky E. Traditional and novel methods to assess and prevent chemotherapy-related cardiac dysfunction noninvasively. J Nucl Cardiol. 2013 Jun; 20(3):443-64. PMID: 23572315.
      Citations:    
    20. Mark S, Calderon-Artero P, Kakinami L, Alexis J, Chen L, Storozynsky E, Fong MW. Review of ambulatory pulmonary artery catheterization in the management of advanced heart failure. Congest Heart Fail. 2012 May-Jun; 18(3):173-8. PMID: 22587747.
      Citations:    
    21. Bergset J, Storozynsky E, Bisognano JD. Renin inhibition for hypertension: selecting the right role for a new class of drug. Am J Ther. 2010 Mar-Apr; 17(2):182-7. PMID: 19433972.
      Citations:    
    22. Uppuluri SC, Storozynsky E, Bisognano JD. Baroreflex device therapy in the treatment of hypertension. Curr Hypertens Rep. 2009 Feb; 11(1):69-75. PMID: 19146804.
      Citations:    
    23. Egan RM, Yorkey C, Black R, Loh WK, Stevens JL, Storozynsky E, Lord EM, Frelinger JG, Woodward JG. In vivo behavior of peptide-specific T cells during mucosal tolerance induction: antigen introduced through the mucosa of the conjunctiva elicits prolonged antigen-specific T cell priming followed by anergy. J Immunol. 2000 May 01; 164(9):4543-50. PMID: 10779755.
      Citations:    
    24. Storozynsky E, Woodward JG, Frelinger JG, Lord EM. Interleukin-3 and granulocyte-macrophage colony-stimulating factor enhance the generation and function of dendritic cells. Immunology. 1999 May; 97(1):138-49. PMID: 10447725.
      Citations:    
    25. Lord EM, Yeh KY, Moran JA, Storozynsky E, Frelinger JG. IL-3-mediated enhancement of particulate antigen presentation by macrophages. J Immunother. 1998 May; 21(3):205-10. PMID: 9610912.
      Citations:    
    26. Wei C, Storozynsky E, McAdam AJ, Yeh KY, Tilton BR, Willis RA, Barth RK, Looney RJ, Lord EM, Frelinger JG. Expression of human prostate-specific antigen (PSA) in a mouse tumor cell line reduces tumorigenicity and elicits PSA-specific cytotoxic T lymphocytes. Cancer Immunol Immunother. 1996 Jul; 42(6):362-8. PMID: 8830740.
      Citations:    
    27. McAdam AJ, Pulaski BA, Storozynsky E, Yeh KY, Sickel JZ, Frelinger JG, Lord EM. Analysis of the effect of cytokines (interleukins 2, 3, 4, and 6, granulocyte-monocyte colony-stimulating factor, and interferon-gamma) on generation of primary cytotoxic T lymphocytes against a weakly immunogenic tumor. Cell Immunol. 1995 Oct 15; 165(2):183-92. PMID: 7553882.
      Citations:    
    28. Agger R, Witmer-Pack M, Romani N, Stossel H, Swiggard WJ, Metlay JP, Storozynsky E, Freimuth P, Steinman RM. Two populations of splenic dendritic cells detected with M342, a new monoclonal to an intracellular antigen of interdigitating dendritic cells and some B lymphocytes. J Leukoc Biol. 1992 Jul; 52(1):34-42. PMID: 1379295.
      Citations:    
    Storozynsky's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (154)
    Explore
    _
    Co-Authors (19)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _